Tropisetron is an indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
Tropisetron appears to be well tolerated with the most frequently reported adverse effect being headache. Extrapyramidal side effects are rare upon using tropisetron.
For the prevention of nausea and vomiting induced by cytotoxic therapy and postoperative.
University Hospital of Basel, Basel, Switzerland
Dep. of Anesthesiology and Pain Therapy, Bern University Hospital, Inselspital, Bern, Switzerland
CHU, Clermont-Ferrand, France
Beijing Hui-Long Guan Hospital, Beijing, China
Baylor College of Medicine - Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
University of Rochester Cancer Center, Rochester, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.